Genotyping Assay Market by Technology (PCR, Sequencing, Microarray, Electrophoresis, MALDI-TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology), and Product - Global Forecast to 2023
“The global genotyping market is projected to grow at a CAGR of 22.0%.”
The genotyping market is expected to reach USD 31.9 billion by 2023 from an estimated USD 11.8 billion in 2018, at a CAGR of 22.0%. Technological advancements, the decreasing prices of DNA sequencing, and the increasing incidence of genetic diseases are expected to drive the growth of the global genotyping market. However, the high cost of equipment is expected to restrain market growth to a certain extent during the forecast period.
“Pharmacogenomics application segment to witness the highest growth during the forecast period.”
On the basis of application, the genotyping market is segmented into pharmacogenomics, diagnostic & personalized medicine, agricultural biotechnology, animal genetics, and other applications. The pharmacogenomics segment is expected to register the highest CAGR during the forecast period. The increased use of genotyping to predict the efficiency of drugs during drug development and the growing need to understand the adverse effects of drugs are the major factors driving the growth of this market segment.
“Pharmaceutical and biopharmaceutical companies end-user segment is expected to grow at the highest CAGR during the forecast period.”
On the basis of end user, the genotyping market is segmented into pharmaceutical & biopharmaceutical companies, diagnostic & research institutes, academic institutes, and other end users. The pharmaceutical & biopharmaceutical companies segment is expected to witness the highest CAGR owing to the growing importance of biomarkers in genotyping used among these end users, given their applications in drug development which, in turn, will support the growth of this segment.
“APAC is projected to witness the highest growth during the forecast period.”
North America is expected to account for the largest share of the global genotyping market in 2018. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing incidence of chronic diseases and growing awareness on the use of genotyping tests to control the inheritance of genetic diseases & the spread of infectious and microbial diseases in APAC countries. The increasing outsourcing of clinical research and trials by pharmaceutical and biopharmaceutical companies to organizations in the APAC has driven the demand for genotyping products for drug profile assessment, drug efficacy, safety assessment, dosing determination, and drug response evaluation.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage:
The report analyzes the market for various genotyping products and their adoption pattern. It aims at estimating the market size and future growth potential of the global genotyping market and different segments such as products, technology, applications, end users, and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.
This report provides insights on the following pointers:
The genotyping market is expected to reach USD 31.9 billion by 2023 from an estimated USD 11.8 billion in 2018, at a CAGR of 22.0%. Technological advancements, the decreasing prices of DNA sequencing, and the increasing incidence of genetic diseases are expected to drive the growth of the global genotyping market. However, the high cost of equipment is expected to restrain market growth to a certain extent during the forecast period.
“Pharmacogenomics application segment to witness the highest growth during the forecast period.”
On the basis of application, the genotyping market is segmented into pharmacogenomics, diagnostic & personalized medicine, agricultural biotechnology, animal genetics, and other applications. The pharmacogenomics segment is expected to register the highest CAGR during the forecast period. The increased use of genotyping to predict the efficiency of drugs during drug development and the growing need to understand the adverse effects of drugs are the major factors driving the growth of this market segment.
“Pharmaceutical and biopharmaceutical companies end-user segment is expected to grow at the highest CAGR during the forecast period.”
On the basis of end user, the genotyping market is segmented into pharmaceutical & biopharmaceutical companies, diagnostic & research institutes, academic institutes, and other end users. The pharmaceutical & biopharmaceutical companies segment is expected to witness the highest CAGR owing to the growing importance of biomarkers in genotyping used among these end users, given their applications in drug development which, in turn, will support the growth of this segment.
“APAC is projected to witness the highest growth during the forecast period.”
North America is expected to account for the largest share of the global genotyping market in 2018. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing incidence of chronic diseases and growing awareness on the use of genotyping tests to control the inheritance of genetic diseases & the spread of infectious and microbial diseases in APAC countries. The increasing outsourcing of clinical research and trials by pharmaceutical and biopharmaceutical companies to organizations in the APAC has driven the demand for genotyping products for drug profile assessment, drug efficacy, safety assessment, dosing determination, and drug response evaluation.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–46%, Tier 2–33%, and Tier 3–21%
- By Designation: C-level–43%, Director Level–35%, and Others–22%
- By Region: North America–34%, Europe–26%, Asia Pacific–19%, Latin America–11%, and the Middle East & Africa–10%
Research Coverage:
The report analyzes the market for various genotyping products and their adoption pattern. It aims at estimating the market size and future growth potential of the global genotyping market and different segments such as products, technology, applications, end users, and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global genotyping market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global genotyping market
- Market Development: Comprehensive information on the lucrative emerging regions by product, technology, application, end user, and region
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global genotyping market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products of leading players in the global genotyping market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 MARKET SEGMENTATION, BY REGION
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 GENOTYPING MARKET OVERVIEW
4.2 ASIA PACIFIC: GENOTYPING MARKET, BY PRODUCT & SERVICE, BY COUNTRY, 2017
4.3 GEOGRAPHIC SNAPSHOT OF THE GENOTYPING MARKET
4.4 GEOGRAPHIC MIX: GENOTYPING MARKET
4.5 GENOTYPING MARKET: DEVELOPING VS. DEVELOPED MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS: IMPACT ANALYSIS
5.3 MARKET DRIVERS
5.3.1 TECHNOLOGICAL ADVANCEMENTS AND DECREASING PRICES OF DNA SEQUENCING
5.3.2 INCREASING INCIDENCE OF GENETIC DISEASES AND RISING AWARENESS ON PERSONALIZED MEDICINE
5.3.3 GROWING IMPORTANCE OF GENOTYPING IN DRUG DEVELOPMENT
5.3.4 INCREASING DEMAND FOR BIOINFORMATICS SOLUTIONS IN DATA ANALYSIS
5.4 MARKET RESTRAINTS
5.4.1 HIGH COST OF EQUIPMENT USED IN GENOTYPING
5.5 MARKET OPPORTUNITIES
5.5.1 GROWING IMPORTANCE OF SEQUENCING PROJECTS
5.5.2 INCREASING APPLICATION AREAS OF GENOTYPING
5.5.3 INCREASING DEMAND FOR GENOME ANALYSIS IN PLANT AND ANIMAL LIVESTOCK
5.6 MARKET CHALLENGES
5.6.1 DATA MANAGEMENT IN GENOTYPING RESEARCH
5.6.2 DEARTH OF TRAINED RESOURCES
6 INDUSTRY INSIGHTS
6.1 INDUSTRY TRENDS
6.1.1 INCREASING DEMAND FOR GENOTYPING & SEQUENCING SERVICES
6.1.2 INCREASING COLLABORATIONS
6.1.3 INCREASING AWARENESS
6.2 REGULATORY ANALYSIS
6.2.1 US
6.2.2 EUROPE
6.2.3 JAPAN
6.2.4 CHINA
6.2.5 INDIA
6.3 STRATEGIC BENCHMARKING
6.3.1 GENOTYPING MARKET: PRODUCT PORTFOLIO ANALYSIS (INSTRUMENTS & KITS)
6.3.2 GENOTYPING MARKET: PRODUCT PORTFOLIO ANALYSIS (BIOINFORMATICS)
7 GENOTYPING MARKET, BY PRODUCT & SERVICE
7.1 INTRODUCTION
7.2 REAGENTS & KITS
7.2.1 REAGENTS & KITS ACCOUNTED FOR THE LARGEST SHARE OF THE GENOTYPING MARKET IN 2017
7.3 GENOTYPING SERVICES
7.3.1 INCREASING DEMAND FOR SEQUENCING AND GENOTYPING SERVICES FROM HOSPITALS, SMALL- AND MEDIUM-SIZED RESEARCH CENTERS, AND PHARMACEUTICAL COMPANIES TO DRIVE THE GROWTH OF THIS SEGMENT
7.4 INSTRUMENTS
7.4.1 SEQUENCERS & AMPLIFIERS
7.4.1.1 Sequencers & amplifiers segment to register the highest growth rate in the genotyping instruments market during the forecast period
7.4.2 ANALYZERS
7.4.2.1 Growing automation and advancements in analyzers with high-throughput capacities are the major factors driving market growth
7.5 BIOINFORMATICS
7.5.1 SOFTWARE
7.5.1.1 Software segment accounted for the largest share of the genotyping bioinformatics market in 2017
7.5.2 SERVICES
7.5.2.1 Shortage of skilled bioinformatics professionals and the growing applications of bioinformatics in various industries are the major factors driving the growth of this segment
8 GENOTYPING MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
8.2 POLYMERASE CHAIN REACTION
8.2.1 REAL-TIME PCR
8.2.1.1 Real-time PCR dominated the PCR market in 2017, primarily due to the growing adoption of these instruments among researchers and healthcare professionals
8.2.2 DIGITAL PCR
8.2.2.1 The high cost of dPCR instruments to restrain the growth of this market
8.3 MICROARRAYS
8.3.1 INCREASING DEMAND FOR PERSONALIZED MEDICINE AND CONTINUOUS LAUNCH OF CUSTOM ARRAYS BY LEADING PLAYERS TO DRIVE MARKET GROWTH
8.4 SEQUENCING
8.4.1 NEXT-GENERATION SEQUENCING
8.4.1.1 NGS to witness the highest growth rate in the sequencing market during the forecast period
8.4.2 PYROSEQUENCING
8.4.2.1 Growing demand for pyrosequencing by pharmaceutical and biotechnology companies to drive the adoption of this technology segment
8.4.3 SANGER SEQUENCING
8.4.3.1 Increasing use of this technology in small-scale experiments is the major factor driving market growth
8.5 CAPILLARY ELECTROPHORESIS
8.5.1 AMPLIFIED FRAGMENT LENGTH POLYMORPHISM
8.5.1.1 AFLP technique to witness the highest growth rate in the capillary electrophoresis market during the forecast period
8.5.2 RESTRICTION FRAGMENT LENGTH POLYMORPHISM
8.5.2.1 Increasing demand for RFLP from forensics, agricultural institutions, and pharmaceutical and biotechnology companies–major factor driving market growth
8.5.3 SINGLE-STRAND CONFORMATION POLYMORPHISM
8.5.3.1 Increasing applications of SSCP in virology are expected to play a key role in the growth of the SSCP market
8.6 MATRIX-ASSISTED LASER DESORPTION/IONIZATION-TIME OF FLIGHT (MALDI-TOF) MASS SPECTROMETRY
8.6.1 INCREASING APPLICATIONS OF THIS TECHNIQUE IN CLINICAL DIAGNOSTICS AND PHARMACOGENOMICS TO DRIVE MARKET GROWTH
8.7 OTHER TECHNOLOGIES
9 GENOTYPING MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 PHARMACOGENOMICS
9.2.1 PHARMACOGENOMICS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE GENOTYPING MARKET IN 2017
9.3 DIAGNOSTICS & PERSONALIZED MEDICINE
9.3.1 TECHNOLOGICAL ADVANCEMENTS AND INCREASING POTENTIAL OF DEVELOPING DIAGNOSTICS TESTS THROUGH RAPID GENOTYPING TECHNIQUES ARE THE KEY FACTORS DRIVING THE GROWTH OF THIS APPLICATION SEGMENT
9.4 ANIMAL GENETICS
9.4.1 LOWER ADOPTION OF GENOTYPING TECHNOLOGIES IN ANIMAL BREEDING PROGRAMS IN DEVELOPING COUNTRIES TO RESTRAIN THE GROWTH OF THIS SEGMENT
9.5 AGRICULTURAL BIOTECHNOLOGY
9.5.1 INCREASING NUMBER OF RESEARCH LABORATORIES AND GREENHOUSES USING PLANT GENOTYPING AND CONTINUOUS PRODUCT INNOVATIONS AND NEW PRODUCT LAUNCHES ARE DRIVING THE GROWTH OF THE AGRICULTURAL BIOTECHNOLOGY SEGMENT
9.6 OTHER APPLICATIONS
10 GENOTYPING MARKET, BY END USER
10.1 INTRODUCTION
10.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
10.2.1 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
10.3 DIAGNOSTIC & RESEARCH LABORATORIES
10.3.1 GROWING PREFERENCE FOR PERSONALIZED MEDICINE AND INCREASING RESEARCH FOCUSED ON PERSONALIZED DIAGNOSIS ARE THE KEY FACTORS DRIVING MARKET GROWTH
10.4 ACADEMIC INSTITUTES
10.4.1 INCREASING RESEARCH ACTIVITIES FOR DRUG DISCOVERY AND RISING INDUSTRY-ACADEMIA COLLABORATIONS FOR DRUG DEVELOPMENT ARE THE KEY FACTORS DRIVING MARKET GROWTH
10.5 OTHER END USERS
11 GENOTYPING MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 US dominated the North American genotyping market in 2018; this trend to continue during the forecast period
11.2.2 CANADA
11.2.2.1 Increasing incidence of genetic diseases & the availability of a wide range of genotyping products to drive market growth in Canada
11.3 EUROPE
11.3.1 GERMANY
11.3.1.1 Germany accounted for the largest share of the European genotyping market in 2017
11.3.2 FRANCE
11.3.2.1 Increasing incidence of genetic disorders & growing public-private investments are driving the growth of the genotyping market in France
11.3.3 UK
11.3.3.1 UK to witness the highest growth in the European genotyping market during the forecast period
11.3.4 ITALY
11.3.4.1 Presence of a well-developed healthcare system and rapid growth in the geriatric population are key factors driving market growth in Italy
11.3.5 SPAIN
11.3.5.1 The lingering effect of economic downturns will continue to affect healthcare in Spain
11.3.6 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 CHINA
11.4.1.1 Infrastructural improvements in China’s healthcare system have boosted treatment rates and care delivery
11.4.2 JAPAN
11.4.2.1 Strong base of pharmaceutical activity will contribute to the use of genotyping
11.4.3 INDIA
11.4.3.1 Growth of the pharmaceutical industry has highlighted the need for better infrastructure in India
11.4.4 REST OF APAC
11.5 LATIN AMERICA
11.6 MIDDLE EAST AND AFRICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 PRODUCT PORTFOLIO MATRIX
12.3 MARKET SHARE ANALYSIS
12.4 COMPETITIVE SITUATIONS AND TRENDS
12.4.1 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
12.4.2 ACQUISITIONS
12.4.3 EXPANSIONS
13 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 ILLUMINA, INC.
13.2 THERMO FISHER SCIENTIFIC, INC.
13.3 ROCHE DIAGNOSTICS LIMITED
13.4 QIAGEN N.V.
13.5 DANAHER CORPORATION
13.6 AGILENT TECHNOLOGIES, INC.
13.7 FLUIDIGM CORPORATION
13.8 GE HEALTHCARE
13.9 GENEWIZ, INC.
13.10 INTEGRATED DNA TECHNOLOGIES, INC. (A SUBSIDIARY OF DANAHER CORPORATION)
13.11 PERKINELMER, INC.
13.12 BIO-RAD LABORATORIES, INC.
13.13 EUROFINS SCIENTIFIC
13.14 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 AVAILABLE CUSTOMIZATIONS
14.5 RELATED REPORT
14.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 MARKET SEGMENTATION, BY REGION
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 GENOTYPING MARKET OVERVIEW
4.2 ASIA PACIFIC: GENOTYPING MARKET, BY PRODUCT & SERVICE, BY COUNTRY, 2017
4.3 GEOGRAPHIC SNAPSHOT OF THE GENOTYPING MARKET
4.4 GEOGRAPHIC MIX: GENOTYPING MARKET
4.5 GENOTYPING MARKET: DEVELOPING VS. DEVELOPED MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS: IMPACT ANALYSIS
5.3 MARKET DRIVERS
5.3.1 TECHNOLOGICAL ADVANCEMENTS AND DECREASING PRICES OF DNA SEQUENCING
5.3.2 INCREASING INCIDENCE OF GENETIC DISEASES AND RISING AWARENESS ON PERSONALIZED MEDICINE
5.3.3 GROWING IMPORTANCE OF GENOTYPING IN DRUG DEVELOPMENT
5.3.4 INCREASING DEMAND FOR BIOINFORMATICS SOLUTIONS IN DATA ANALYSIS
5.4 MARKET RESTRAINTS
5.4.1 HIGH COST OF EQUIPMENT USED IN GENOTYPING
5.5 MARKET OPPORTUNITIES
5.5.1 GROWING IMPORTANCE OF SEQUENCING PROJECTS
5.5.2 INCREASING APPLICATION AREAS OF GENOTYPING
5.5.3 INCREASING DEMAND FOR GENOME ANALYSIS IN PLANT AND ANIMAL LIVESTOCK
5.6 MARKET CHALLENGES
5.6.1 DATA MANAGEMENT IN GENOTYPING RESEARCH
5.6.2 DEARTH OF TRAINED RESOURCES
6 INDUSTRY INSIGHTS
6.1 INDUSTRY TRENDS
6.1.1 INCREASING DEMAND FOR GENOTYPING & SEQUENCING SERVICES
6.1.2 INCREASING COLLABORATIONS
6.1.3 INCREASING AWARENESS
6.2 REGULATORY ANALYSIS
6.2.1 US
6.2.2 EUROPE
6.2.3 JAPAN
6.2.4 CHINA
6.2.5 INDIA
6.3 STRATEGIC BENCHMARKING
6.3.1 GENOTYPING MARKET: PRODUCT PORTFOLIO ANALYSIS (INSTRUMENTS & KITS)
6.3.2 GENOTYPING MARKET: PRODUCT PORTFOLIO ANALYSIS (BIOINFORMATICS)
7 GENOTYPING MARKET, BY PRODUCT & SERVICE
7.1 INTRODUCTION
7.2 REAGENTS & KITS
7.2.1 REAGENTS & KITS ACCOUNTED FOR THE LARGEST SHARE OF THE GENOTYPING MARKET IN 2017
7.3 GENOTYPING SERVICES
7.3.1 INCREASING DEMAND FOR SEQUENCING AND GENOTYPING SERVICES FROM HOSPITALS, SMALL- AND MEDIUM-SIZED RESEARCH CENTERS, AND PHARMACEUTICAL COMPANIES TO DRIVE THE GROWTH OF THIS SEGMENT
7.4 INSTRUMENTS
7.4.1 SEQUENCERS & AMPLIFIERS
7.4.1.1 Sequencers & amplifiers segment to register the highest growth rate in the genotyping instruments market during the forecast period
7.4.2 ANALYZERS
7.4.2.1 Growing automation and advancements in analyzers with high-throughput capacities are the major factors driving market growth
7.5 BIOINFORMATICS
7.5.1 SOFTWARE
7.5.1.1 Software segment accounted for the largest share of the genotyping bioinformatics market in 2017
7.5.2 SERVICES
7.5.2.1 Shortage of skilled bioinformatics professionals and the growing applications of bioinformatics in various industries are the major factors driving the growth of this segment
8 GENOTYPING MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
8.2 POLYMERASE CHAIN REACTION
8.2.1 REAL-TIME PCR
8.2.1.1 Real-time PCR dominated the PCR market in 2017, primarily due to the growing adoption of these instruments among researchers and healthcare professionals
8.2.2 DIGITAL PCR
8.2.2.1 The high cost of dPCR instruments to restrain the growth of this market
8.3 MICROARRAYS
8.3.1 INCREASING DEMAND FOR PERSONALIZED MEDICINE AND CONTINUOUS LAUNCH OF CUSTOM ARRAYS BY LEADING PLAYERS TO DRIVE MARKET GROWTH
8.4 SEQUENCING
8.4.1 NEXT-GENERATION SEQUENCING
8.4.1.1 NGS to witness the highest growth rate in the sequencing market during the forecast period
8.4.2 PYROSEQUENCING
8.4.2.1 Growing demand for pyrosequencing by pharmaceutical and biotechnology companies to drive the adoption of this technology segment
8.4.3 SANGER SEQUENCING
8.4.3.1 Increasing use of this technology in small-scale experiments is the major factor driving market growth
8.5 CAPILLARY ELECTROPHORESIS
8.5.1 AMPLIFIED FRAGMENT LENGTH POLYMORPHISM
8.5.1.1 AFLP technique to witness the highest growth rate in the capillary electrophoresis market during the forecast period
8.5.2 RESTRICTION FRAGMENT LENGTH POLYMORPHISM
8.5.2.1 Increasing demand for RFLP from forensics, agricultural institutions, and pharmaceutical and biotechnology companies–major factor driving market growth
8.5.3 SINGLE-STRAND CONFORMATION POLYMORPHISM
8.5.3.1 Increasing applications of SSCP in virology are expected to play a key role in the growth of the SSCP market
8.6 MATRIX-ASSISTED LASER DESORPTION/IONIZATION-TIME OF FLIGHT (MALDI-TOF) MASS SPECTROMETRY
8.6.1 INCREASING APPLICATIONS OF THIS TECHNIQUE IN CLINICAL DIAGNOSTICS AND PHARMACOGENOMICS TO DRIVE MARKET GROWTH
8.7 OTHER TECHNOLOGIES
9 GENOTYPING MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 PHARMACOGENOMICS
9.2.1 PHARMACOGENOMICS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE GENOTYPING MARKET IN 2017
9.3 DIAGNOSTICS & PERSONALIZED MEDICINE
9.3.1 TECHNOLOGICAL ADVANCEMENTS AND INCREASING POTENTIAL OF DEVELOPING DIAGNOSTICS TESTS THROUGH RAPID GENOTYPING TECHNIQUES ARE THE KEY FACTORS DRIVING THE GROWTH OF THIS APPLICATION SEGMENT
9.4 ANIMAL GENETICS
9.4.1 LOWER ADOPTION OF GENOTYPING TECHNOLOGIES IN ANIMAL BREEDING PROGRAMS IN DEVELOPING COUNTRIES TO RESTRAIN THE GROWTH OF THIS SEGMENT
9.5 AGRICULTURAL BIOTECHNOLOGY
9.5.1 INCREASING NUMBER OF RESEARCH LABORATORIES AND GREENHOUSES USING PLANT GENOTYPING AND CONTINUOUS PRODUCT INNOVATIONS AND NEW PRODUCT LAUNCHES ARE DRIVING THE GROWTH OF THE AGRICULTURAL BIOTECHNOLOGY SEGMENT
9.6 OTHER APPLICATIONS
10 GENOTYPING MARKET, BY END USER
10.1 INTRODUCTION
10.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
10.2.1 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
10.3 DIAGNOSTIC & RESEARCH LABORATORIES
10.3.1 GROWING PREFERENCE FOR PERSONALIZED MEDICINE AND INCREASING RESEARCH FOCUSED ON PERSONALIZED DIAGNOSIS ARE THE KEY FACTORS DRIVING MARKET GROWTH
10.4 ACADEMIC INSTITUTES
10.4.1 INCREASING RESEARCH ACTIVITIES FOR DRUG DISCOVERY AND RISING INDUSTRY-ACADEMIA COLLABORATIONS FOR DRUG DEVELOPMENT ARE THE KEY FACTORS DRIVING MARKET GROWTH
10.5 OTHER END USERS
11 GENOTYPING MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 US dominated the North American genotyping market in 2018; this trend to continue during the forecast period
11.2.2 CANADA
11.2.2.1 Increasing incidence of genetic diseases & the availability of a wide range of genotyping products to drive market growth in Canada
11.3 EUROPE
11.3.1 GERMANY
11.3.1.1 Germany accounted for the largest share of the European genotyping market in 2017
11.3.2 FRANCE
11.3.2.1 Increasing incidence of genetic disorders & growing public-private investments are driving the growth of the genotyping market in France
11.3.3 UK
11.3.3.1 UK to witness the highest growth in the European genotyping market during the forecast period
11.3.4 ITALY
11.3.4.1 Presence of a well-developed healthcare system and rapid growth in the geriatric population are key factors driving market growth in Italy
11.3.5 SPAIN
11.3.5.1 The lingering effect of economic downturns will continue to affect healthcare in Spain
11.3.6 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 CHINA
11.4.1.1 Infrastructural improvements in China’s healthcare system have boosted treatment rates and care delivery
11.4.2 JAPAN
11.4.2.1 Strong base of pharmaceutical activity will contribute to the use of genotyping
11.4.3 INDIA
11.4.3.1 Growth of the pharmaceutical industry has highlighted the need for better infrastructure in India
11.4.4 REST OF APAC
11.5 LATIN AMERICA
11.6 MIDDLE EAST AND AFRICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 PRODUCT PORTFOLIO MATRIX
12.3 MARKET SHARE ANALYSIS
12.4 COMPETITIVE SITUATIONS AND TRENDS
12.4.1 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
12.4.2 ACQUISITIONS
12.4.3 EXPANSIONS
13 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 ILLUMINA, INC.
13.2 THERMO FISHER SCIENTIFIC, INC.
13.3 ROCHE DIAGNOSTICS LIMITED
13.4 QIAGEN N.V.
13.5 DANAHER CORPORATION
13.6 AGILENT TECHNOLOGIES, INC.
13.7 FLUIDIGM CORPORATION
13.8 GE HEALTHCARE
13.9 GENEWIZ, INC.
13.10 INTEGRATED DNA TECHNOLOGIES, INC. (A SUBSIDIARY OF DANAHER CORPORATION)
13.11 PERKINELMER, INC.
13.12 BIO-RAD LABORATORIES, INC.
13.13 EUROFINS SCIENTIFIC
13.14 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 AVAILABLE CUSTOMIZATIONS
14.5 RELATED REPORT
14.6 AUTHOR DETAILS
LIST OF TABLES
Table 1 STANDARD CURRENCY CONVERSION RATES
Table 2 GENOTYPING MARKET SNAPSHOT, 2018 VS. 2023
Table 3 COMPARATIVE DATA: OLDER VS LATEST PLATFORMS, BY COMPANY
Table 4 RECENT DEVELOPMENTS IN THE GENOTYPING MARKET
Table 5 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
Table 6 GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 7 GENOTYPING REAGENTS & KITS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 8 GENOTYPING SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 9 GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
Table 10 GENOTYPING INSTRUMENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 11 GENOTYPING SEQUENCERS & AMPLIFIERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 12 GENOTYPING ANALYZERS MARKET, BY COUNTRY, 2016–2023 ( USD MILLION)
Table 13 GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023, (USD MILLION)
Table 14 GENOTYPING BIOINFORMATICS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 15 GENOTYPING BIOINFORMATICS SOFTWARE MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 16 GENOTYPING BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 17 GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 18 COMPARATIVE STUDY: REAL-TIME PCR VS DIGITAL PCR
Table 19 POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 20 POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 21 MAJOR REAL-TIME PCR PRODUCTS AVAILABLE IN THE MARKET
Table 22 REAL-TIME PCR MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 23 MAJOR DIGITAL PCR PRODUCTS AVAILABLE IN THE MARKET
Table 24 DIGITAL PCR MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 25 MAJOR MICROARRAY PRODUCTS AVAILABLE IN THE MARKET
Table 26 MICROARRAYS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 27 SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 28 SEQUENCING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 29 MAJOR NEXT-GENERATION SEQUENCING PRODUCTS AVAILABLE IN THE MARKET
Table 30 NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 31 MAJOR PYROSEQUENCING PRODUCTS AVAILABLE IN THE MARKET
Table 32 PYROSEQUENCING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 33 MAJOR SANGER SEQUENCING PRODUCTS AVAILABLE IN THE MARKET
Table 34 SANGER SEQUENCING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 35 CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 36 CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 37 MAJOR AFLP PRODUCTS AVAILABLE IN THE MARKET
Table 38 AMPLIFIED FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 39 MAJOR RFLP PRODUCTS AVAILABLE IN THE MARKET
Table 40 RESTRICTION FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 41 MAJOR SSCP PRODUCTS AVAILABLE IN THE MARKET
Table 42 SINGLE-STRAND CONFORMATION POLYMORPHISM MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 43 MAJOR MALDI-TOF PRODUCTS AVAILABLE IN THE MARKET
Table 44 MALDI-TOF MASS SPECTROMETRY MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 45 MAJOR PRODUCTS AVAILABLE IN THE MARKET
Table 46 GENOTYPING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 47 GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 48 GENOTYPING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 49 GENOTYPING MARKET FOR DIAGNOSTICS & PERSONALIZED MEDICINE, BY COUNTRY, 2016–2023 (USD MILLION)
Table 50 GENOTYPING MARKET FOR ANIMAL GENETICS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 51 GENOTYPING MARKET FOR AGRICULTURAL BIOTECHNOLOGY, BY COUNTRY, 2016–2023 (USD MILLION)
Table 52 GENOTYPING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 53 GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 54 GENOTYPING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 55 GENOTYPING MARKET FOR DIAGNOSTIC AND RESEARCH LABORATORIES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 56 GENOTYPING MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 57 GENOTYPING MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 58 GENOTYPING MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 59 NORTH AMERICA: GENOTYPING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 60 NORTH AMERICA: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 61 NORTH AMERICA: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 62 NORTH AMERICA: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 63 NORTH AMERICA: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 64 NORTH AMERICA: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 65 NORTH AMERICA: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 66 NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 67 NORTH AMERICA: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 68 NORTH AMERICA: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 69 US: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 70 US: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 71 US: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 72 US: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 73 US: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 74 US: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 75 US: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 76 US: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 77 US: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 78 CANADA: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 79 CANADA: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 80 CANADA: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 81 CANADA: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 82 CANADA: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 83 CANADA: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 84 CANADA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 85 CANADA: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 86 CANADA: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 87 EUROPE: GENOTYPING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 88 EUROPE: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 89 EUROPE: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 90 EUROPE: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 91 EUROPE: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 92 EUROPE: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 93 EUROPE: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 94 EUROPE: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 95 EUROPE: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 96 EUROPE: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 97 GERMANY: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 98 GERMANY: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 99 GERMANY: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 100 GERMANY: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 101 GERMANY: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 102 GERMANY: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 103 GERMANY: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 104 GERMANY: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 105 GERMANY: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 106 FRANCE: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 107 FRANCE: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 108 FRANCE: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 109 FRANCE: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 110 FRANCE: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 111 FRANCE: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 112 FRANCE: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 113 FRANCE: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 114 FRANCE: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 115 UK: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 116 UK: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 117 UK: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 118 UK: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 119 UK: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 120 UK: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 121 UK: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 122 UK: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 123 UK: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 124 ITALY: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 125 ITALY: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 126 ITALY: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 127 ITALY: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 128 ITALY: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 129 ITALY: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 130 ITALY: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 131 ITALY: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 132 ITALY: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 133 SPAIN: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 134 SPAIN: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 135 SPAIN: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 136 SPAIN: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 137 SPAIN: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 138 SPAIN: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 139 SPAIN: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 140 SPAIN: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 141 SPAIN: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 142 ROE: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 143 ROE: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 144 ROE: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 145 ROE: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 146 ROE: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 147 ROE: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 148 ROE: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 149 ROE: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 150 ROE: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 151 APAC: GENOTYPING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 152 APAC: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 153 APAC: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 154 APAC: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 155 APAC: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 156 APAC: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 157 APAC: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 158 APAC: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 159 APAC: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 160 APAC: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 161 CHINA: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 162 CHINA: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 163 CHINA: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 164 CHINA: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 165 CHINA: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 166 CHINA: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 167 CHINA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 168 CHINA: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 169 CHINA: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 170 JAPAN: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 171 JAPAN: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 172 JAPAN: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 173 JAPAN: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 174 JAPAN: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 175 JAPAN: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 176 JAPAN: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 177 JAPAN: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 178 JAPAN: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 179 INDIA: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 180 INDIA: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 181 INDIA: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 182 INDIA: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 183 INDIA: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 184 INDIA: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 185 INDIA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 186 INDIA: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 187 INDIA: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 188 ROAPAC: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 189 ROAPAC: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 190 ROAPAC: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 191 ROAPAC: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 192 ROAPAC: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 193 ROAPAC: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 194 ROAPAC: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 195 ROAPAC: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 196 ROAPAC: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 197 LATIN AMERICA: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 198 LATIN AMERICA: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 199 LATIN AMERICA: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 200 LATIN AMERICA: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 201 LATIN AMERICA: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 202 LATIN AMERICA: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 203 LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 204 LATIN AMERICA: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 205 LATIN AMERICA: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 206 MEA: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 207 MEA: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 208 MEA: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 209 MEA: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 210 MEA: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 211 MEA: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 212 MEA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 213 MEA: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 214 MEA: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 215 GROWTH STRATEGY MATRIX (2015–2018)
Table 216 PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, 2015–2018
Table 217 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2015–2018
Table 218 ACQUISITIONS, 2015–2018
Table 219 EXPANSIONS, 2015–2018
Table 1 STANDARD CURRENCY CONVERSION RATES
Table 2 GENOTYPING MARKET SNAPSHOT, 2018 VS. 2023
Table 3 COMPARATIVE DATA: OLDER VS LATEST PLATFORMS, BY COMPANY
Table 4 RECENT DEVELOPMENTS IN THE GENOTYPING MARKET
Table 5 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
Table 6 GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 7 GENOTYPING REAGENTS & KITS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 8 GENOTYPING SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 9 GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
Table 10 GENOTYPING INSTRUMENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 11 GENOTYPING SEQUENCERS & AMPLIFIERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 12 GENOTYPING ANALYZERS MARKET, BY COUNTRY, 2016–2023 ( USD MILLION)
Table 13 GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023, (USD MILLION)
Table 14 GENOTYPING BIOINFORMATICS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 15 GENOTYPING BIOINFORMATICS SOFTWARE MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 16 GENOTYPING BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 17 GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 18 COMPARATIVE STUDY: REAL-TIME PCR VS DIGITAL PCR
Table 19 POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 20 POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 21 MAJOR REAL-TIME PCR PRODUCTS AVAILABLE IN THE MARKET
Table 22 REAL-TIME PCR MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 23 MAJOR DIGITAL PCR PRODUCTS AVAILABLE IN THE MARKET
Table 24 DIGITAL PCR MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 25 MAJOR MICROARRAY PRODUCTS AVAILABLE IN THE MARKET
Table 26 MICROARRAYS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 27 SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 28 SEQUENCING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 29 MAJOR NEXT-GENERATION SEQUENCING PRODUCTS AVAILABLE IN THE MARKET
Table 30 NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 31 MAJOR PYROSEQUENCING PRODUCTS AVAILABLE IN THE MARKET
Table 32 PYROSEQUENCING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 33 MAJOR SANGER SEQUENCING PRODUCTS AVAILABLE IN THE MARKET
Table 34 SANGER SEQUENCING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 35 CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 36 CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 37 MAJOR AFLP PRODUCTS AVAILABLE IN THE MARKET
Table 38 AMPLIFIED FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 39 MAJOR RFLP PRODUCTS AVAILABLE IN THE MARKET
Table 40 RESTRICTION FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 41 MAJOR SSCP PRODUCTS AVAILABLE IN THE MARKET
Table 42 SINGLE-STRAND CONFORMATION POLYMORPHISM MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 43 MAJOR MALDI-TOF PRODUCTS AVAILABLE IN THE MARKET
Table 44 MALDI-TOF MASS SPECTROMETRY MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 45 MAJOR PRODUCTS AVAILABLE IN THE MARKET
Table 46 GENOTYPING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 47 GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 48 GENOTYPING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 49 GENOTYPING MARKET FOR DIAGNOSTICS & PERSONALIZED MEDICINE, BY COUNTRY, 2016–2023 (USD MILLION)
Table 50 GENOTYPING MARKET FOR ANIMAL GENETICS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 51 GENOTYPING MARKET FOR AGRICULTURAL BIOTECHNOLOGY, BY COUNTRY, 2016–2023 (USD MILLION)
Table 52 GENOTYPING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 53 GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 54 GENOTYPING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 55 GENOTYPING MARKET FOR DIAGNOSTIC AND RESEARCH LABORATORIES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 56 GENOTYPING MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 57 GENOTYPING MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 58 GENOTYPING MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 59 NORTH AMERICA: GENOTYPING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 60 NORTH AMERICA: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 61 NORTH AMERICA: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 62 NORTH AMERICA: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 63 NORTH AMERICA: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 64 NORTH AMERICA: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 65 NORTH AMERICA: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 66 NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 67 NORTH AMERICA: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 68 NORTH AMERICA: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 69 US: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 70 US: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 71 US: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 72 US: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 73 US: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 74 US: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 75 US: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 76 US: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 77 US: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 78 CANADA: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 79 CANADA: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 80 CANADA: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 81 CANADA: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 82 CANADA: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 83 CANADA: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 84 CANADA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 85 CANADA: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 86 CANADA: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 87 EUROPE: GENOTYPING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 88 EUROPE: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 89 EUROPE: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 90 EUROPE: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 91 EUROPE: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 92 EUROPE: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 93 EUROPE: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 94 EUROPE: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 95 EUROPE: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 96 EUROPE: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 97 GERMANY: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 98 GERMANY: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 99 GERMANY: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 100 GERMANY: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 101 GERMANY: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 102 GERMANY: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 103 GERMANY: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 104 GERMANY: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 105 GERMANY: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 106 FRANCE: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 107 FRANCE: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 108 FRANCE: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 109 FRANCE: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 110 FRANCE: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 111 FRANCE: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 112 FRANCE: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 113 FRANCE: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 114 FRANCE: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 115 UK: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 116 UK: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 117 UK: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 118 UK: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 119 UK: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 120 UK: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 121 UK: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 122 UK: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 123 UK: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 124 ITALY: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 125 ITALY: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 126 ITALY: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 127 ITALY: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 128 ITALY: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 129 ITALY: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 130 ITALY: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 131 ITALY: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 132 ITALY: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 133 SPAIN: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 134 SPAIN: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 135 SPAIN: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 136 SPAIN: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 137 SPAIN: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 138 SPAIN: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 139 SPAIN: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 140 SPAIN: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 141 SPAIN: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 142 ROE: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 143 ROE: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 144 ROE: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 145 ROE: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 146 ROE: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 147 ROE: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 148 ROE: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 149 ROE: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 150 ROE: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 151 APAC: GENOTYPING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 152 APAC: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 153 APAC: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 154 APAC: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 155 APAC: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 156 APAC: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 157 APAC: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 158 APAC: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 159 APAC: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 160 APAC: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 161 CHINA: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 162 CHINA: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 163 CHINA: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 164 CHINA: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 165 CHINA: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 166 CHINA: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 167 CHINA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 168 CHINA: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 169 CHINA: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 170 JAPAN: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 171 JAPAN: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 172 JAPAN: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 173 JAPAN: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 174 JAPAN: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 175 JAPAN: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 176 JAPAN: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 177 JAPAN: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 178 JAPAN: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 179 INDIA: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 180 INDIA: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 181 INDIA: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 182 INDIA: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 183 INDIA: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 184 INDIA: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 185 INDIA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 186 INDIA: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 187 INDIA: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 188 ROAPAC: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 189 ROAPAC: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 190 ROAPAC: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 191 ROAPAC: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 192 ROAPAC: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 193 ROAPAC: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 194 ROAPAC: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 195 ROAPAC: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 196 ROAPAC: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 197 LATIN AMERICA: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 198 LATIN AMERICA: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 199 LATIN AMERICA: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 200 LATIN AMERICA: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 201 LATIN AMERICA: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 202 LATIN AMERICA: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 203 LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 204 LATIN AMERICA: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 205 LATIN AMERICA: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 206 MEA: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
Table 207 MEA: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 208 MEA: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 209 MEA: GENOTYPING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
Table 210 MEA: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 211 MEA: SEQUENCING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 212 MEA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 213 MEA: GENOTYPING MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 214 MEA: GENOTYPING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 215 GROWTH STRATEGY MATRIX (2015–2018)
Table 216 PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, 2015–2018
Table 217 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2015–2018
Table 218 ACQUISITIONS, 2015–2018
Table 219 EXPANSIONS, 2015–2018
The global genotyping market is expected to reach $17.0 Billion in 2020 from $ 6.2 Billion in 2015, at a healthy CAGR of 22.3% from 2015 to 2020.
Growth in this market is attributed to the increasing incidence of genetic diseases & increasing awareness about personalized medicine, technological advancements, decreasing prices of DNA sequencing, growing importance of SNP genotyping in drug development, and the increasing demand for genetic analysis in animal & plant livestock. However, the lack of appropriate reimbursement policies and a lack of technical know-how are curbing market growth to a certain extent.
Key players in Genotyping Market are
- Affymetrix, Inc. (U.S.)
- Illumina, Inc. (U.S.)
- Thermo Fisher Scientific, Inc. (U.S.)
- Agilent Technologies (U.S.)
- Beckman Coulter (U.S.)
- Sequenom, Inc. (U.S.)
The global genotyping market is segmented by products & services, technology, applications, end users, and region. This report also discusses the key market drivers, restraints, opportunities, and challenges for this market and submarkets. The market, by products & services, is segmented into instruments (sequencers & amplifiers, and analyzers), reagents & kits, bioinformatics software and genotyping services. The reagents & kits market segment accounted for the largest share of 49% of the global genotyping market in 2014. The accessibility of a wide range of reagents and increasing need for genotyping for assessing drug efficacy and safety, to personalize the treatment for chronic diseases, to develop good breeds of animals & plants are some of the factors that are expected to drive the genotyping reagents market.
North America, a major market for global genotyping, occupied a major share in this market, closely followed by Europe. However, emerging countries in the Asia-Pacific region and the Rest of the World (Latin America) are expected to record strong growth during the forecast period. The Asia-Pacific market is expected to grow at a CAGR of 25.4% during the forecast period of 2015-2020. Countries like India, China, and Brazil will majorly drive market growth owing to the introduction of healthcare reforms, rising investments by public and private players to provide improved healthcare services in these countries, and the unmet medical needs of patients suffering from diseases such as cancer, diabetes and cardiovascular disease.
